XXII · 22nd Century Group, Inc. · Exempt Offerings
$1.55
-0.38 (-19.69%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Given the Company's projected operating requirements and its existing cash and cash equivalents, there is substantial doubt about the Company's ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued. Management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$19,080
Shares
12,310
Volume · Nov 6
489.21K
Avg daily vol (2 sessions)
421.91K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-10-04 | New | Biotechnology | $1,200,000 | $1,200,000 | 06b |
| 2024-04-19 | New | Biotechnology | $4,200,000 | $4,200,000 | 06b |
| 2022-07-29 | New | Biotechnology | $35,000,009 | $35,000,009 | 06b |
| 2022-05-27 | Amendment | Biotechnology | $58,003,000 | $58,003,000 | 06b |
| 2022-05-25 | New | Biotechnology | $58,003,000 | $58,003,000 | 06b |
Showing 1–5 of 5 filings
Key facts
CIK
1347858
CUSIP
90137F707
13F (30d)
19 filings
9 filers
Visit website
Investor relations